Horizon Therapeutics Plc Long Term Debt

Horizon Therapeutics Plc (HZNP) currently reports a long-term debt of $2.5B as of June 2023. That compares with $2.6B in the prior-year period — down 0.4% year over year. Use the charts on this page to explore Horizon Therapeutics Plc's long-term debt history and peer comparisons.

Horizon Therapeutics Plc's long-term debt decreased from $2.6B to $2.5B — a 0.4% year-over-year decrease (period ending June 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Horizon Therapeutics Plc reported $2.5B in long-term debt as of June 2023. That compares with $2.6B in the prior-year period — down 0.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current long-term debt of $2.5B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Horizon Therapeutics Plc, and consider following HZNP for alerts when major investors trade the stock.

Horizon Therapeutics Plc is classified in the Healthcare sector. On long-term debt, it currently shows $2.5B. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing HZNP with unrelated industries.